Evidence map›Paper›PMID 36001187›Full record

ArticleGlycoconjugate journal2022

Proceedings of workshop: "Neuroglycoproteins in health and disease", INNOGLY cost action.

Esther Llop, Ana Ardá, Elsa Zacco, Roisin O'Flaherty, María-Salud García-Ayllón, Massimo Aureli, Moran Frenkel-Pinter, Celso A Reis, Ole K Greiner-Tollersrud, Inmaculada Cuchillo-Ibáñez

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Glycoconjugate journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. LC-MS/MS Isomeric Profiling ofBiomolecules · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 6 countries.

Esther LlopDepartment of Biology, Biochemistry and Molecular Biology Unit, University of Girona, 17003, Girona, Spain.
Ana ArdáIkerbasque, Basque Foundation for Science, Maria Diaz de Haro 3, 48013 Bilbao, Bizkaia, Spain.
Elsa ZaccoItalian Institute of Technology, Genova, Italy.
Roisin O'FlahertyDepartment of Chemistry, Maynooth University, Maynooth, Co. Kildare, Ireland.
María-Salud García-AyllónLaboratorio de Investigación, Hospital General Universitario de Elche, Fundació para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, Alicante, Spain.
Massimo AureliDepartment of Medical Biotechnology and Translational Medicine, University of Milano, via Fratelli Cervi 93, 20090, Segrate, MI, Italy.
Moran Frenkel-PinterThe Center for Nanoscience and Nanotechnology, Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel.
Celso A ReisInstituto de Investigação E Inovação Em Saúde, Universidade Do Porto, Porto, Portugal.
Ole K Greiner-TollersrudInstitute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.
Inmaculada Cuchillo-IbáñezInstituto de Neurociencias de Alicante, Universidad Miguel Hernández de Elche-CSIC, Sant Joan d'Alacant, Spain. icuchillo@umh.es.ORCID 0000-0002-3689-5518
Universitat de Miguel Hernández d'Elx · ESHebrew University of Jerusalem · ILIkerbasque · ESItalian Institute of Technology · ITNational University of Ireland, Maynooth · IEUiT The Arctic University of Norway · NOUniversidade do Porto · PTUniversitat de Girona · ESUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Cost Action "Innovation with glycans: new frontiers from synthesis to new biological targets" (INNOGLY) hosted the Workshop "Neuroglycoproteins in health and disease", in Alicante, Spain, on March 2022. This event brought together an european group of scientists that presented novel insights into changes in glycosylation in diseases of the central nervous system and cancer, as well as new techniques to study protein glycosylation. Herein we provide the abstracts of all the presentations.

Indexed as

NeoplasmsPolysaccharidesGlycosylationHumansPolysaccharidesCancerGlyco-enzimesGlycosylationLectinsMass-spectrometryNeurodegenerative diseasesNMR

Identifiers

PMID36001187
PMCPMC9399589
OpenAlexW4292879103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.